Exploring immune interactions in triple negative breast cancer: IL-1β inhibition and its therapeutic potential

por Wilson, Brooke E., Shen, Qiang, Cescon, David W., Reedijk, Michael
Publicado 2023

Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations

por Wilson, Brooke E., Desnoyers, Alexandra, Nadler, Michelle B., Tibau, Ariadna, Amir, Eitan
Publicado 2021

A retrospective analysis of changes in distant and breast cancer related disease-free survival events in adjuvant breast cancer trials over time

por Wilson, Brooke E., Desnoyers, Alexandra, Al-Showbaki, Laith, Nadler, Michelle B., Amir, Eitan
Publicado 2022

Augmenting clinical trial economic analysis by linking cancer trial data to administrative data: current landscape and future opportunities

por Wilson, Brooke E, Hay, Annette E, Chan, Kelvin Kar-Wing, Cheung, Matthew C, Hanna, Timothy P
Publicado 2023

Perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40–49

por Nadler, Michelle B., Corrado, Ann Marie, Wilson, Brooke E., Desnoyers, Alexandra, Amir, Eitan, Ivers, Noah, Desveaux, Laura
Publicado 2023

Ecological effects of cefepime use during antibiotic cycling on the Gram-negative enteric flora of ICU patients

por Venturini, Carola, Ginn, Andrew N., Wilson, Brooke E., Tsafnat, Guy, Paulsen, Ian, Partridge, Sally R., Iredell, Jonathan R.
Publicado 2018

Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes

por Bratti, Vanessa F, Wilson, Brooke E, Fazelzad, Rouhi, Pabani, Aliyah, Zurn, Shalini J, Johnson, Sonali, Sung, Lillian, Rodin, Danielle
Publicado 2023

Determinants of guideline-concordant breast cancer screening by family physicians for women aged 40–49 years: a qualitative analysis

por Nadler, Michelle B., Corrado, Ann Marie, Desveaux, Laura, Neil-Sztramko, Sarah E., Wilson, Brooke E., Desnoyers, Alexandra, Amir, Eitan, Ivers, Noah
Publicado 2022

Are NCCN Resource-Stratified Guidelines for Breast Cancer Systemic Therapy Achievable? A Population-Based Study of Global Need and Economic Impact

por Wilson, Brooke E., Jacob, Susannah, Do, Viet, Amir, Eitan, Bray, Freddie, Ferlay, Jacques, Knaul, Felicia M., Elawawy, Ahmed, Pearson, Sallie-Anne, Barton, Michael B.
Publicado 2021

Global Cancer Drug Development—A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting

por Wilson, Brooke E., Sullivan, Richard, Peto, Richard, Abubakar, Bello, Booth, Christopher, Werutsky, Gustavo, Adams, Cary, Saint-Raymond, Agnes, Fleming, Thomas R., Lyerly, Kim, Gralow, Julie R.
Publicado 2023

Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302

por Wilson, Brooke E., Armstrong, Andrew J., de Bono, Johann, Sternberg, Cora N., Ryan, Charles J., Scher, Howard I., Smith, Matthew R., Rathkopf, Dana, Logothetis, Christopher J., Chi, Kim N., Jones, Robert J., Saad, Fred, De Porre, Peter, Tran, NamPhuong, Hu, Peter, Gillessen, Silke, Carles, Joan, Fizazi, Karim, Joshua, Anthony M.
Publicado 2022